- Home
- CTMX vs IH Comparison
CTMX vs IH Comparison
Compare CTMX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- IH
- Stock Information
- Founded
- CTMX 2008
- IH 1996
- Country
- CTMX United States
- IH China
- Employees
- CTMX N/A
- IH N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- CTMX Health Care
- IH Real Estate
- Exchange
- CTMX Nasdaq
- IH Nasdaq
- Market Cap
- CTMX 62.3M
- IH 96.9M
- IPO Year
- CTMX 2015
- IH 2020
- Fundamental
- Price
- CTMX $0.80
- IH $1.85
- Analyst Decision
- CTMX Buy
- IH
- Analyst Count
- CTMX 6
- IH 0
- Target Price
- CTMX $5.77
- IH N/A
- AVG Volume (30 Days)
- CTMX 731.5K
- IH 21.6K
- Earning Date
- CTMX 03-10-2025
- IH 02-27-2025
- Dividend Yield
- CTMX N/A
- IH 4.54%
- EPS Growth
- CTMX N/A
- IH N/A
- EPS
- CTMX 0.16
- IH 0.28
- Revenue
- CTMX $126,617,000.00
- IH $134,002,994.00
- Revenue This Year
- CTMX $22.55
- IH $15.90
- Revenue Next Year
- CTMX N/A
- IH $8.64
- P/E Ratio
- CTMX $4.93
- IH $6.65
- Revenue Growth
- CTMX 33.66
- IH N/A
- 52 Week Low
- CTMX $0.75
- IH $1.47
- 52 Week High
- CTMX $5.85
- IH $2.48
- Technical
- Relative Strength Index (RSI)
- CTMX 41.61
- IH 63.52
- Support Level
- CTMX $0.75
- IH $1.69
- Resistance Level
- CTMX $0.98
- IH $1.70
- Average True Range (ATR)
- CTMX 0.06
- IH 0.08
- MACD
- CTMX 0.00
- IH 0.02
- Stochastic Oscillator
- CTMX 20.13
- IH 92.59
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.